Evidence map›Paper›PMID 24850901›Full record

ArticleMolecular cancer research : MCR2014

Hypoxia regulates alternative splicing of HIF and non-HIF target genes.

Johnny A Sena, Liyi Wang, Lynn E Heasley, Cheng-Jun Hu

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Targeting ferroptosis for precision medicine in cervical cancer.Apoptosis : an international journal on programmed cell death · 2025
    Review
  4. Review
  5. Association betweenFrontiers in medicine · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer.Journal of experimental & clinical cancer research : CR · 2020
    Review
  17. Molecular Deregulation ofFrontiers in oncology · 2020
    Article
  18. Article
  19. Regulation of Gene Expression under Hypoxic Conditions.International journal of molecular sciences · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Johnny A SenaMolecular Biology Graduate Program and.
Liyi WangDepartment of Craniofacial Biology, School of Dental Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Lynn E HeasleyDepartment of Craniofacial Biology, School of Dental Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Cheng-Jun HuMolecular Biology Graduate Program and Department of Craniofacial Biology, School of Dental Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado Cheng-jun.hu@ucdenver.edu.
Molecular Biology Consortium · USUniversity of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Regulation of Transcriptional Activity of Hypoxia Inducible Factor 2R01CA134687 · NCI · UNIVERSITY OF COLORADO DENVER · PI HU, CHENG-JUN · 2008 to 2012
$1.5M
NCI NIH HHS P30 CA046934NCI NIH HHS R01 CA134687NCI NIH HHS R01CA134687NCI NIH HHS R01CA134687-S3NCI NIH HHS R01CA134687-S4
6 · The paper itself

Abstract

unlabelledHypoxia is a common characteristic of many solid tumors. The hypoxic microenvironment stabilizes hypoxia-inducible transcription factor 1α (HIF1α) and 2α (HIF2α/EPAS1) to activate gene transcription, which promotes tumor cell survival. The majority of human genes are alternatively spliced, producing RNA isoforms that code for functionally distinct proteins. Thus, an effective hypoxia response requires increased HIF target gene expression as well as proper RNA splicing of these HIF-dependent transcripts. However, it is unclear if and how hypoxia regulates RNA splicing of HIF targets. This study determined the effects of hypoxia on alternative splicing (AS) of HIF and non-HIF target genes in hepatocellular carcinoma cells and characterized the role of HIF in regulating AS of HIF-induced genes. The results indicate that hypoxia generally promotes exon inclusion for hypoxia-induced, but reduces exon inclusion for hypoxia-reduced genes. Mechanistically, HIF activity, but not hypoxia per se is found to be necessary and sufficient to increase exon inclusion of several HIF targets, including pyruvate dehydrogenase kinase 1 (PDK1). PDK1 splicing reporters confirm that transcriptional activation by HIF is sufficient to increase exon inclusion of PDK1 splicing reporter. In contrast, transcriptional activation of a PDK1 minigene by other transcription factors in the absence of endogenous HIF target gene activation fails to alter PDK1 RNA splicing. IMPLICATIONS: This study demonstrates a novel function of HIF in regulating RNA splicing of HIF target genes.

Indexed as

Alternative SplicingBasic Helix-Loop-Helix ProteinsCell HypoxiaCell Line, TumorCell SurvivalEndothelial PAS Domain-Containing Protein 1ExonsGene Expression Regulation, NeoplasticHumansHypoxia-Inducible Factor 1, alpha SubunitProtein Serine-Threonine KinasesPyruvate Dehydrogenase Acetyl-Transferring KinaseRNA SplicingTranscriptional ActivationBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1HIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitPDK1 protein, humanProtein Serine-Threonine KinasesPyruvate Dehydrogenase Acetyl-Transferring Kinase

Identifiers

PMID24850901
PMCPMC4163527
OpenAlexW2170373941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.